The dose-dependent analgesic effects, abuse liability, safety and tolerability of oral cannabidiol in healthy humans - Arout CA, Haney M, Herrmann ES, Bedi G, Cooper ZD.
AIMS: Preclinical studies demonstrate that cannabidiol (CBD) elicits an antinociceptive response in animal models of neuropathic pain; in humans, limited data are available to support such analgesic effects. Few studies have examined CBD's analgesic effect...
Source: SafetyLit - Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news
More News: Alcoholism | Brain | International Medicine & Public Health | Neurology | Pain | Study | Substance Abuse